Rapamycin Clinical Trials
8 recruitingDrug
Phase 24Phase 33Phase 11Early Phase 11Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 1
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Large B-cell Lymphoma
Nanjing IASO Biotechnology Co., Ltd.70 enrolled2 locationsNCT06743503
Recruiting
Early Phase 1
RESTOR: PK/PD mTORi Inhibition in Older Adults
Aging
The University of Texas Health Science Center at San Antonio194 enrolled1 locationNCT06658093
Recruiting
Phase 2
Rapamycin - Effects on Alzheimer's and Cognitive Health
Alzheimer DiseaseMild Cognitive Impairment
The University of Texas Health Science Center at San Antonio40 enrolled1 locationNCT04629495
Recruiting
Phase 2Phase 3
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
AgelessRx150 enrolled1 locationNCT07092618
Recruiting
Phase 2
The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage
Communicating HydrocephalusCerebral Intraventricular HemorrhageSecondary Normal Pressure Hydrocephalus+1 more
Beijing Tiantan Hospital53 enrolled1 locationNCT06563817
Recruiting
Not Applicable
mTOR as Mediator of Insulin Sensitivity Study
Insulin Sensitivity
University of Copenhagen10 enrolled1 locationNCT05233722
Recruiting
Phase 2Phase 3
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Tuberous Sclerosis Complex
Katarzyna Kotulska60 enrolled2 locationsNCT04987463
Recruiting
Phase 3
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Tuberous Sclerosis Complex
Katarzyna Kotulska200 enrolled2 locationsNCT05534672